Net profit of Nath Bio-Genes (India) declined 43.51% to Rs 1.48 crore in the quarter ended March 2025 as against Rs 2.62 crore during the previous quarter ended March 2024. Sales rose 20.75% to Rs 51.97 crore in the quarter ended March 2025 as against Rs 43.04 crore during the previous quarter ended March 2024.
For the full year,net profit declined 2.57% to Rs 38.60 crore in the year ended March 2025 as against Rs 39.62 crore during the previous year ended March 2024. Sales rose 9.71% to Rs 364.91 crore in the year ended March 2025 as against Rs 332.62 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 51.97 | 43.04 | 21 | 364.91 | 332.62 | 10 |
| OPM % | 0.81 | 9.13 | - | 13.64 | 14.99 | - |
| PBDT | 2.91 | 3.27 | -11 | 43.86 | 41.38 | 6 |
| PBT | 1.57 | 2.28 | -31 | 40.04 | 38.11 | 5 |
| NP | 1.48 | 2.62 | -44 | 38.60 | 39.62 | -3 |